Microbot Medical closes first tranche of preferred investment options raising $25.2M

Hingham, MA, September 16, 2025 (Globe Newswire) -- Microbot Medical announced the first closing of its exercise of outstanding preferred investment options, raising $25.2 million, with a second closing of $4 million expected by October 15, 2025. The exercise allows investors to purchase up to ~14 million common shares, with new short-term series J preferred options issued at $4.50 per share, exercisable six months after issuance for two years. If fully exercised, total gross proceeds could reach approximately $92.2 million.

Read full article here.